Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating D064 and D702 combination therapy versus monotherapy in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• D064
• D702

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED